Entebbe Airport Emerges as a Possible Intersection in Two Ebola Investigations
Health officials are examining whether two Ebola patients, one now being treated in Nigeria and another who died in Kenya, may have crossed paths at Uganda’s main airport earlier this month. Both travellers passed through Entebbe on 3 October, creating a narrow but important epidemiological question: did they share a common exposure, or did their journeys simply overlap in time and place without direct contact?
The answer is still unknown. Investigators have not established any link between the cases, and the airport remains only one of several possible points of exposure under review. Yet the timing is difficult to ignore. When a virus spreads across borders in a region with heavy cross-border movement, a single transit hub can become a critical node in the chain of transmission, especially if people are moving between areas where outbreaks are already active.
Dr Wessam Mankoula of the Africa Centres for Disease Control and Prevention said an interaction at the airport is one possible scenario. He also made clear that no direct connection has been proven. The inquiry is now focused on whether the two patients used the same facilities, handled shared equipment, or encountered any contaminated object during transit.
Nigeria’s Case: Improvement in Isolation, Exposure Still Unclear
Nigeria’s patient is a 42-year-old Ugandan-born woman living in Abuja. She is receiving treatment in isolation and is improving, according to the World Health Organization. Her husband, a Swiss diplomat who travelled with her to Uganda, is also in isolation and has not developed symptoms.
Her route back to Nigeria is clinically important because it adds multiple jurisdictions and travel legs to an already complicated exposure history. She returned on 3 October after spending about two and a half weeks in Uganda, and her itinerary included a two-hour stopover in Addis Ababa. Symptoms began four days after she arrived in Abuja, followed by visits to two private health facilities before Ebola was confirmed on 20 October.
That sequence leaves several unresolved possibilities. Infection may have occurred during her stay in Uganda, during transit, or through an exposure that has not yet been identified. Public health teams are therefore reconstructing every movement, because even small gaps in the timeline can alter contact tracing priorities and the interpretation of the outbreak’s origin.
One sentence carries the weight of the entire investigation: the source of exposure is still unknown.
The WHO has said complete interviewing has been difficult because opportunities to speak with the patient were limited while she remained in hospital. Nigeria’s Centre for Disease Control and Prevention is carrying out genomic sequencing, which may help determine whether the infection is linked to other cases or whether it reflects a separate chain of transmission. Genomic work cannot replace field epidemiology, but it can sharpen it by showing whether two infections are closely related at the viral level.
Kenya’s Cluster Remains Linked, Not Widespread
In Kenya, the man who died was the first recorded Ebola death in the current outbreak. Health Director-General Dr Patrick Amoth said all nine confirmed infections are linked to that first patient, and there is no evidence of wider community transmission. The first group of people quarantined after possible exposure is expected to return home on Sunday after 21 days of monitoring without symptoms.
Eight patients remain in isolation and are responding well to treatment. That pattern matters because Ebola control depends less on broad population measures than on fast interruption of transmission chains. When cases remain linked and contacts complete monitoring without illness, public health teams gain evidence that containment measures are still working. When unlinked cases appear in separate places, the picture changes quickly.
Border Movement, Silent Transmission Windows and the Limits of Screening
The present concern is not only about the two named patients. It is also about the volume of movement between the Democratic Republic of Congo and neighbouring Uganda, where thousands of people cross daily for trade, work and family visits. Those routes are hard to police completely, especially when travellers use unofficial crossings and when symptoms have not yet begun.
Ebola does not spread before symptoms appear, but infected travellers can move through airports, buses, and border posts before falling ill. Once fever, weakness, vomiting or diarrhoea begin, the risk of direct transmission rises sharply through bodily fluids or contaminated objects. That biological reality is why health agencies push so hard for contact tracing, rapid isolation and early treatment. If those steps happen late, even a small cluster can become a regional problem.
Dr Patrick Otim of the WHO said Uganda has no confirmed active Ebola cases and that travel through the country does not automatically mean the woman was infected there. He also warned that investigators have not yet received verified confirmation that she travelled to eastern DR Congo, despite earlier suggestions from Ugandan officials. The travel history remains under reconstruction, and the uncertainty is now part of the epidemiology.
Contact Tracing Expands as Health Workers and Family Members Are Monitored
Nigeria’s health authorities have identified additional people who may have been exposed to the woman, beyond the 44 contacts initially reported. Most of those newly identified contacts are healthcare workers in facilities where she received treatment, along with a smaller number of family members. High-risk contacts are being prioritised for quarantine, although authorities have not yet released a final updated total.
The emphasis on healthcare workers is unsurprising. In Ebola outbreaks, clinical settings can become amplification points when a patient arrives before the diagnosis is known, particularly if standard precautions are delayed. Early treatment in private facilities, before confirmation, often expands the contact list quickly because clinicians, nurses, laboratory staff and family members all enter the exposure network.
Dr Pavel Ursu, the WHO representative in Nigeria, said the patient is receiving a high standard of care and is clinically stable. Even so, the public health stakes remain high. Stability in one patient does not resolve the larger transmission question, especially when the source of infection is still being pieced together and genomic sequencing is pending.
Regional vigilance is now the central instruction from Africa CDC and the WHO. Dr Mohamed Janabi, the WHO’s regional director for Africa, urged countries to strengthen surveillance, investigate infections and protect frontline health workers. For now, the investigation rests on a simple but consequential question: whether two travellers moving through the same airport on the same day were linked by a shared exposure, or whether the overlap is only a reminder of how quickly Ebola can move across borders when surveillance gaps remain open.